What are the recent trends in market size and growth for the pen needles market?
The pen needles market size has grown rapidly in recent years. It will grow from $2.42 billion in 2024 to $2.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the invention of the insulin pen, miniaturization technology, focus on patient convenience, enhanced needle design, and safety features implementation.
The pen needles market size is expected to see rapid growth in the next few years. It will grow to $4.21 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to compatibility with different insulin pens, customization options, material innovations, integration with digital health solutions, and regulatory guidelines and standards. Major trends in the forecast period include user-friendly design, improved needle coatings, environmentally friendly materials, and smart technology integration.
Get Your Free Sample of The Global Pen Needles Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15632&type=smp
What key drivers have fueled the pen needles market’s development over the years?
The increasing prevalence of diabetes is expected to propel the growth of the pen needles market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body’s ineffective utilization of insulin. The increasing prevalence of diabetes can be attributed to factors such as sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Pen needles are indispensable tools for diabetes management, enabling precise insulin delivery through convenient, minimally invasive injections, promoting better glycemic control, and enhancing patient compliance. For instance, in 2021, according to the International Diabetes Federation, a Belgium-based organization, the projected number of individuals living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the growth of the pen needles market.
What is the segmentation for the pen needles market?
The pen needles market covered in this report is segmented –
1) By Type: Standard Pen Needles, Safety Pen Needles
2) By Needle Length: Short Length Pen Needles, Medium Length Pen Needles, Long Length Pen Needles
3) By Therapy: Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone
4) Mode Of Purchase: Retail, Non-Retail
5) By End User: Hospitals And Clinics, Home Healthcare, Other End Users
Subsegments:
1) By Standard Pen Needles: Fixed-Needle Pen Needles, Removable-Needle Pen Needles, Short Pen Needles ( 4mm, 5mm), Long Pen Needles ( 8mm, 12mm)
2) By Safety Pen Needles: Automatic Safety Pen Needles, Manual Safety Pen Needles, Retractable Safety Pen Needles, Shielded Safety Pen Needles
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/pen-needles-global-market-report
Who are the most influential companies in the pen needles market?
Major companies operating in the pen needles market are Cardinal Health Inc., Novartis AG, F. Hoffmann-La Roche AG, Novo Nordisk AS, Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Tandem Diabetes Care Inc., Trividia Health Inc., Medical Technology and Devices S.p.A., Owen Mumford, Dynarex Corporation, Arkray Inc., UltiMed Inc., Montmed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., Simple Diagnostics Inc., Stat Medical Inc., HTL-STREFA S.A., Hindustan Syringes & Medical Devices Ltd.
What are the top industry trends projected to impact the pen needles market?
Major companies operating in the pen needle market are focusing on developing advanced technologies, such as thin-wall technology, to reduce the need for pressure during injection. Thin-wall technology is a needle design that enlarges the internal diameter to enable faster medication flow with less injection pressure, improving patient comfort. For instance, in May 2022, Roche Diabetes Care Ltd., a Switzerland-based pharmaceutical company, launched ACCU-FINE pen needles, designed to provide virtually painless insulin delivery. The ACCU-FINE needles feature a special cut for gentle insertion, along with a special coating that allows for smooth gliding into the skin. This design minimizes discomfort during injections. The needles have a thin wall, which facilitates more rapid insulin flow, ensuring efficient delivery of the medication. Each needle comes with two protective covers, including a sealed sterile protective cap and an additional protective cap that ensures safe handling and storage. ACCU-FINE needles are compatible with all common insulin pens, making them versatile for various users regardless of their specific insulin delivery device.
What are the major regional insights for the pen needles market, and which region holds the top position?
North America was the largest region in the pen needles market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pen needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Pen Needles Market Report 2025 Offer?
The pen needles market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Pen needles refer to small, disposable devices used to administer insulin via insulin pens, designed for subcutaneous injection. They feature a thin, sharp needle for minimal discomfort and are available in various lengths and gauges to accommodate different patient needs and preferences. These needles are important in managing diabetes by facilitating convenient and precise insulin delivery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15632
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
